Internal medicine, Cervical intraepithelial neoplasia, Cervical cancer, Immunology and Gynecology are her primary areas of study. Cosette M. Wheeler combines subjects such as Vaccine efficacy and Vaccination with her study of Internal medicine. Her work carried out in the field of Cervical intraepithelial neoplasia brings together such families of science as Oncology, Colposcopy, Relative risk, Papillomaviridae and HPV vaccines.
Her Cervical cancer research is multidisciplinary, relying on both Carcinoma in situ and Virus. Her Immunology research incorporates themes from Genital warts, Carcinoma and HLA-DQ Antigen. Cosette M. Wheeler has included themes like Placebo, Epidemiology and Human papillomavirus in her Gynecology study.
Cosette M. Wheeler mainly investigates Cervical intraepithelial neoplasia, Cervical cancer, Internal medicine, Gynecology and Papillomaviridae. Her biological study spans a wide range of topics, including Cervical screening, Cytology, Colposcopy and Vaccination. In Cervical cancer, Cosette M. Wheeler works on issues like Immunology, which are connected to Haplotype.
Her Internal medicine study combines topics in areas such as Oncology and Vaccine efficacy. Her research integrates issues of Odds ratio, Epidemiology, Cervix, Obstetrics and Risk factor in her study of Gynecology. Her studies deal with areas such as Viral Vaccine, Genotype and Virology as well as Papillomaviridae.
Her main research concerns Cervical intraepithelial neoplasia, Cervical cancer, Internal medicine, Gynecology and Vaccination. Her work deals with themes such as Young adult, Papillomaviridae, Cervical screening, Cytology and Obstetrics, which intersect with Cervical intraepithelial neoplasia. Her Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Vaccine efficacy.
The concepts of her Gynecology study are interwoven with issues in Human papillomavirus and Mass screening. Her Vaccination research includes themes of Clinical trial, Incidence, Randomized controlled trial, HPV infection and Cohort. Her HPV infection study incorporates themes from Squamous intraepithelial lesion and Immunology.
Cosette M. Wheeler mainly investigates Cervical intraepithelial neoplasia, Internal medicine, Cervical cancer, Papillomaviridae and Young adult. Her Cervical intraepithelial neoplasia research is multidisciplinary, incorporating elements of Gynecology, HPV infection and Vaccination. She has researched Vaccination in several fields, including Incidence, HPV vaccines and Cohort.
Her research in Internal medicine is mostly concerned with Cancer. Her research in Cervical cancer intersects with topics in Family medicine and Biostatistics. Her Papillomaviridae research is multidisciplinary, incorporating perspectives in Cytology, Genotyping Techniques and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
Suzanne M. Garland;Suzanne M. Garland;Mauricio Hernandez-Avila;Cosette M. Wheeler;Gonzalo Perez.
The New England Journal of Medicine (2007)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris.
The Lancet (2004)
A controlled trial of a human papillomavirus type 16 vaccine.
Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler;Darron R. Brown.
The New England Journal of Medicine (2002)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Diane M Harper;Eduardo L Franco;Cosette M Wheeler;Anna-Barbara Moscicki.
The Lancet (2006)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)
Improved Amplification of Genital Human Papillomaviruses
P. E. Gravitt;C. L. Peyton;T. Q. Alessi;C. M. Wheeler.
Journal of Clinical Microbiology (2000)
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method
P. E. Gravitt;C. L. Peyton;R. J. Apple;C. M. Wheeler.
Journal of Clinical Microbiology (1998)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn.
Lancet Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: